Australia markets closed

CONMED Corporation (CNMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
71.08-1.68 (-2.31%)
At close: 04:00PM EDT
71.08 +0.01 (+0.01%)
After hours: 04:01PM EDT

CONMED Corporation

11311 Concept Boulevard
Largo, FL 33773-4908
United States
727 392 6464
https://www.conmed.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees4,000

Key executives

NameTitlePayExercisedYear born
Mr. Curt R. HartmanChairman of the Board, CEO & President2.45MN/A1964
Ms. Heather L. CohenExecutive VP, Chief Human Resources & Legal Officer and Secretary820.47k463.2k1973
Mr. Patrick J. BeyerPresident of International & Global Orthopedics1.6MN/A1966
Mr. Stanley W. Peters IIIPresident of Advanced Surgical & Advanced Endoscopic Technologies897.08k1.04M1975
Mr. Peter K. ShagoryExecutive Vice President of Strategy & Corporate DevelopmentN/AN/A1969
Ms. Shanna L. Cotti-OsmanskiExecutive VP of Information Technology & CION/AN/A1977
Mr. John FerrellExecutive Vice President of Human ResourcesN/AN/A1968
Mr. Daniel S. Jonas Esq.Special Counsel & Corporate Secretary646.48k3.51M1964
Mr. David R. MurrayPresident of ConMed Electrosurgery469.17kN/A1948
Mr. Terence M. BergeVP & Corporate ControllerN/AN/A1970
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Corporate governance

CONMED Corporation’s ISS governance QualityScore as of 1 April 2024 is 3. The pillar scores are Audit: 3; Board: 4; Shareholder rights: 3; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.